stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Dr. Reddy's Laboratories Ltd (RDY)
- AMNEAL PHARMACEUTICALS, INC. AMRX 20.11 +3.39%
- Dr. Reddy's Laboratories Ltd RDY 14.86 +2.27%
AMNEAL PHARMACEUTICALS, INC. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $12.1B against $6.8B — 1.8× the size. AMNEAL PHARMACEUTICALS, INC. trades at the lower P/E: 36.9× against 44.4×. AMNEAL PHARMACEUTICALS, INC. grew revenue faster over the last twelve months: 8.88% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs 4.17%) and the lower return on invested capital (4.77% vs 8.45%). Across the 21 metrics below, Dr. Reddy's Laboratories Ltd leads on 11 and AMNEAL PHARMACEUTICALS, INC. on 10.
Valuation
Profitability
| Metric | AMRX | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 49.16% | 53.51% |
| Operating margin | 14.99% | 9.20% | 0.00% |
| Net margin | 4.17% | 8.06% | (2.45%) |
| Free cash flow margin | (1.89%) | 2.88% | 0.00% |
| Return on equity | (53,107.17%) | 6.60% | (0.80%) |
| Return on assets | 3.01% | 4.44% | (1.67%) |
| Return on invested capital | 8.45% | 4.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack